United States
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 24, 2006
IMS HEALTH INCORPORATED
----------------------------
(Exact name of registrant as specified in its charter)
Delaware 001-14049 06-1506026
----------------- ----------------- -----------------
(State or other (Commission File Number) (IRS Employer Identification No.)
jurisdiction of
incorporation)
1499 Post Road, Fairfield, Connecticut 06824
----------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (203) 319-4700
Not Applicable
----------------------------------------------
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
|_| Written communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)
|_| Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
|_| Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
|_| Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
--------------------------------------------------------------------------------
Item 5.02 Departure of Directors or Principal Officers; Election of Directors;
Appointment of Principal Officers
On July 24, 2006, Nancy E. Cooper tendered her resignation as Senior Vice
President and Chief Financial Officer of IMS Health Incorporated (the
"Company"), effective August 7, 2006. On July 28, 2006, the Company issued a
press release announcing Ms. Cooper's resignation. A copy of the press release
is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
Exhibit No. Description
99.1 Press release issued by IMS Health Incorporated, dated
July 28, 2006.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
IMS HEALTH INCORPORATED
By: /s/ Robert H. Steinfeld
-----------------------------------
Robert H. Steinfeld
Senior Vice President, General
Counsel and Corporate Secretary
Date: July 28, 2006
EXHIBIT INDEX
Exhibit No. Description
99.1 Press release issued by IMS Health Incorporated, dated
July 28, 2006.